“…For instance, one study has reported that healthy adults with an average age of 40 to 86 years old exhibit elevated serum B2M levels with progressive aging. Similar findings have been reported in other studies (20)(21)(22)(23). Additionally, B2M in the older Chinese population can reportedly affect both the frailty phenotype and index.…”